UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053880
Receipt number R000061503
Scientific Title Investigation of the effect of continuous consumption of gummy candies containing reduced coenzyme Q10 on oral-related quality of life with increased saliva secretion.
Date of disclosure of the study information 2024/03/17
Last modified on 2024/03/17 14:31:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the effect of continuous consumption of gummy candies containing reduced coenzyme Q10 on oral-related quality of life with increased saliva secretion.

Acronym

Investigating the effects of continuous consumption of gummy candies containing reduced coenzyme Q10 on quality of life

Scientific Title

Investigation of the effect of continuous consumption of gummy candies containing reduced coenzyme Q10 on oral-related quality of life with increased saliva secretion.

Scientific Title:Acronym

Investigating the effects of continuous consumption of gummy candies containing reduced coenzyme Q10 on quality of life

Region

Japan


Condition

Condition

healthy people

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluating whether continuous intake of gummies containing reduced coenzyme Q10 increases salivary secretion, thereby causing changes in oral health-related parameters

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Stimulated saliva production and oral-related quality of life after 8 weeks of test food consumption.

Key secondary outcomes

Oral function test, saliva test, Assessment of eating discomfort and taste, Dietary Variety Score, Test food usage and health awareness survey


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Consume 2 gummy candies containing reduced coenzyme Q10 per day for 8 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Persons with dry mouth sensation
Age 40 and over

Key exclusion criteria

Persons who are allergic to any of the components of the test food or reagent solution
Those who are taking more than 6 drugs.
Those who are taking drugs with an incidence of 5% or more of those listed as "xerostomia," "dry mouth," or "dysgeusia" in the adverse drug reactions in the package insert information of ethical drugs. If the frequency of occurrence is listed as "frequency unknown" in the accompanying information, the incidence is considered to be less than 5%.
Persons undergoing treatment for xerostomia
Persons with a history of epilepsy, Parkinson's disease, or Sjogren's syndrome, persons who have undergone or will undergo radiation therapy of the head and neck region, and persons who have undergone or will undergo anticancer drug therapy.
Persons who are unable to eat the test food
Person who smokes
Persons who are deemed ineligible by the dentist in charge of the examination
Persons who are deemed ineligible by the investigator.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name MARIKO
Middle name
Last name MAEDA

Organization

SUNSTAR INC.

Division name

Research and Development Division

Zip code

566-0002

Address

7F, KENTO Innovation Park NK Building, 3-17 Senrioka Shinmachi, Settsu, Osaka

TEL

090-8807-7530

Email

mariko.maeda@jp.sunstar.com


Public contact

Name of contact person

1st name KENTARO
Middle name
Last name IKEDA

Organization

SUNSTAR INC.

Division name

Research and Development Division

Zip code

566-0002

Address

7F, KENTO Innovation Park NK Building, 3-17 Senrioka Shinmachi, Settsu, Osaka

TEL

090-8807-7530

Homepage URL


Email

kentaro.ikeda@jp.sunstar.com


Sponsor or person

Institute

SUNSTAR INC.

Institute

Department

Personal name



Funding Source

Organization

SUNSTAR INC.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

SUNSTAR INC. Validity Assessment Committee

Address

3-1 Asahimachi, Takatsuki-shi, Osaka, Japan

Tel

090-8807-7530

Email

takeshi.kanamori@jp.sunstar.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

サンスター株式会社 大阪サテライト研究所(大阪府)


Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

29

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 07 Month 21 Day

Date of IRB

2023 Year 07 Month 21 Day

Anticipated trial start date

2023 Year 08 Month 02 Day

Last follow-up date

2023 Year 11 Month 30 Day

Date of closure to data entry

2023 Year 12 Month 08 Day

Date trial data considered complete

2023 Year 12 Month 15 Day

Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2024 Year 03 Month 17 Day

Last modified on

2024 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061503


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name